About Asence Pharma Private Limited
Data last updated:
Asence Pharma Private Limited is a private limited company based in Vadodara, Gujarat, India, a subsidiary of Asence Inc. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 14 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2004PTC045141. Its GSTIN is 24AAFCA3471M1ZL (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹9.1 Cr and a paid-up capital of ₹9.1 Cr. It is led by directors including Mohal Kartikeya Sarabhai (Managing Director) and Ashokkumar Shah.
Its last annual general meeting (AGM) was held on 09 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Asence House Gorwa Road, Vadodara, Gujarat, India – 390023.
As per the financials filed for FY 2025, the company reported a revenue of ₹77.56 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹3.21 Cr (net margin 4.1%) and EBITDA of ₹6.86 Cr (EBITDA margin 8.9%).
The company has about 60 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary and 1 joint venture.
The company is associated with 2 brands: Asence and Sarabhai. As per MCA filings, the company has open charges of ₹32.69 Cr and satisfied charges of ₹10.74 Cr on record. Court records list 2 cases involving the company, including 1 filed against it. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹9 Cr; the latest was in March 2021. Its 10 peer companies in the Pharma industry (API Manufacturers, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Pratap Organics Private Limited with revenue of ₹78.04 Cr. The company has 9 MSME Form 1 returns on record between 2019 and 2024, listing 49 overdue payments to 17 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ase.life.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressAsence House Gorwa Road, Vadodara, Gujarat, India – 390023
- IndustryPharma, API Manufacturers, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Asence Pharma Private Limited
The main business activity of Asence Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Asence Pharma Private Limited FY 2025 filings available
Asence Pharma Private Limited reported revenue of ₹77.56 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Asence Pharma Private Limited
Revenue rose 22% in the latest year. EBITDA rose 80% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Asence Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹77.56 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.86 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.21 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Asence Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Asence Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Asence Pharma Private Limited
Asence Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pratap Organics Private Limited | ₹78.04 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Navi Mumbai, Maharashtra, India |
| Lark Laboratories (India) Ltd | ₹77.99 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | New Delhi, Delhi, India |
| Astra Lifecare (India) Private Limited | ₹77.75 Cr (FY 2019) | •••• | •••• | -26.0% | •••• | Ahmedabad, Gujarat, India |
| V-Ensure Pharma Technologies Private Limited | ₹77.73 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Navi Mumbai, Maharashtra, India |
| Universal Medicare Private Limited | ₹77.59 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Mumbai, Maharashtra, India |
| Asence Pharma Private Limited this company | ₹77.56 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Vadodara, Gujarat, India |
| J P N Pharma Private Limited | ₹77.5 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Vasa Pharma Chem Pvt Ltd | ₹77.38 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Ahmedabad, Gujarat, India |
| Vimal Drugs Private Limited | ₹76.99 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Hyderabad, Telangana, India |
| Vineet Laboratories Limited Listed | ₹76.98 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Hyderabad, Telangana, India |
| Vapi Care Pharma Private Limited | ₹76.81 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Vapi, Valsad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Asence Pharma by revenue in the Pharma industry (API Manufacturers, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Asence Pharma Private Limited
Asence Pharma Private Limited is audited by Sorab S. Engineer & Co. for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Sorab S. Engineer & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Asence Pharma Private Limited
Asence Pharma has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashokkumar Shah Also directs: Sarabhai Chemicals (India) Private Limited, Sarabhai M. Chemicals Limited, Suvik Hitek Pvt Ltd and 2 more | Director | 02 Jul 2019 | 7 Years 3 Months | Current |
| Mayurkumar Kishorchandra Swadia Also directs: Ambalal Sarabhai Enterprises Limited, Synbiotics Limited, Systronics India Ltd and 5 more | Director | 09 Nov 2020 | 5 Years 11 Months | Current |
| Mohal Kartikeya Sarabhai Also directs: Ambalal Sarabhai Enterprises Limited, Cosara Diagnostics Private Limited, Vovantis Laboratories Private Limited and 5 more | Managing Director | 18 May 2005 | 21 Years 4 Months | Current |
| Umesh Shah | Director | 29 Jun 2017 | 9 Years 3 Months | Current |
Ownership and Shareholding of Asence Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Asence Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2024 | Others | ₹2.2 Cr | Open |
| 03 Mar 2023 | Others | ₹1 Cr | Open |
| 02 Jan 2023 | Bank of India | ₹7 Cr | Open |
| 29 Dec 2022 | Bank of India | ₹7 Cr | Open |
| 03 Aug 2022 | Others | ₹1.99 Cr | Open |
Total charge records: 11 View all charges
Deals & Funding of Asence Pharma Private Limited
Asence Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹9 Cr; the latest was in March 2021.
Deals on record (1 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2007 | Secondary share transfer | Undisclosed | Buyer: Asence Inc Seller: 2 individuals |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Asence Pharma Private Limited
Asence Pharma Private Limited has 2 court cases on record: 1 filed against it, 1 where it is another party. All cases are disposed. Status as checked between 21 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Vadodara, Gujarat | Commercial matter | Filed against the company by Agile Pharmachem A Sole Proprietorship Firm Its | Disposed |
| District court, Vadodara, Gujarat | Court case (REF IT) | Company is another party | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Asence Pharma Private Limited
Asence Pharma Private Limited has 9 MSME Form 1 returns on record between 2019 and 2024, listing 49 overdue payments to 17 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 17)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Shree Nath Life Sciences Private Limited | •••• | •••• | •••• |
| Catapharma Chemicals Private Limited | •••• | •••• | •••• |
| Vaidhatru Pharma Private Limited | •••• | •••• | •••• |
| Centurion Remedies Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 9 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Asence Pharma Private Limited
Asence Pharma operates two associated brands: Asence and Sarabhai. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supply chain services for pharmaceutical products are provided by Asence. | asence.com | |
| Pharmaceuticals, diagnostics, and electronics manufacturing in India. | ase.life |
Employees and EPFO Compliance at Asence Pharma Private Limited
Asence Pharma Private Limited has a workforce of 60 employees as of Oct 10, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Asence Pharma Private Limited
Asence Pharma has 1 subsidiary company and 1 joint venture. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Synbiotics Limited | U24232GJ1960PLC000992 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Asence Pharma Private Limited
Asence Pharma Private Limited has 11 board changes on record since 2005: 4 appointments and 7 cessations. The latest: Mohal Kartikeya Sarabhai ceased to be Director on 01 Apr 2022.
19 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Asence Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Asence Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Asence Pharma Private Limited
Asence Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCA3471M1ZL | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Asence Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asence Pharma Private Limited
Asence Pharma is an active private limited company based in Vadodara, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 14 December 2004 (22+ years old) and is registered under CIN U24230GJ2004PTC045141.
Asence Pharma reported revenue of ₹77.56 Cr for FY 2025 (up 22% YoY).
Asence Pharma has 4 current directors:
- Mohal Kartikeya Sarabhai - Managing Director
- Ashokkumar Shah - Director
- Mayurkumar Kishorchandra Swadia - Director
- Umesh Shah - Director
Asence Pharma reported a net profit of ₹3.21 Cr (net margin 4.1%) and EBITDA of ₹6.86 Cr (EBITDA margin 8.9%) for FY 2025, as per its filed financial statements.
The GSTIN of Asence Pharma is 24AAFCA3471M1ZL, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Asence Pharma is U24230GJ2004PTC045141. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Asence Pharma has 2 court cases on record: 1 filed against it.
Asence Pharma was incorporated on 14 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Asence Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹9 Cr; the latest was in March 2021.
The peers of Asence Pharma by revenue are Pratap Organics Private Limited, Lark Laboratories (India) Ltd, Astra Lifecare (India) Private Limited, V-Ensure Pharma Technologies Private Limited, Universal Medicare Private Limited and 5 more, all in the Pharma industry (API Manufacturers, Formulations).
Mohal Kartikeya Sarabhai ceased to be Director on 01 Apr 2022. Mayurkumar Kishorchandra Swadia ceased to be Additional Director on 14 Sep 2021. Mayurkumar Kishorchandra Swadia was appointed as Director on 09 Nov 2020. Asence Pharma has 11 board changes on record in total.
Asence Pharma has 9 MSME Form 1 returns on record between 2019 and 2024, listing 49 overdue payments to 17 micro and small suppliers. The latest return was filed on 22 Apr 2024.